Dr. Pierantonio Russo, Corporate Chief Medical Officer at EVERSANA, brings over 20 years of experience in cardiac and heart transplant surgery, along with extensive expertise in data and analytics, health economics, and population medicine. Having held leadership positions at prominent institutions such as Temple University, St. Christopher’s Hospital, and the University of Missouri, Dr. Russo has been instrumental in advancing the fields of cardiac surgery and healthcare innovation. His academic background includes a Certificate in Health Care Innovation from the University of Pennsylvania and a Certificate in Digital Medicine from Node Health. Dr. Russo's tenure at EVERSANA is marked by his efforts to bridge clinical and commercialization processes, enhancing post-launch strategies through medical data analysis and patient engagement. His expertise in machine learning and predictive analytics informs telehealth strategies, while his innovative approaches in data, AI, and digital health revolutionize care for rare disease patients. His insights into the future of digitally connected hospitals and his role in integrating clinical and commercial strategies enforce EVERSANA’s commitment to advancing healthcare outcomes through innovation.